Onconetix, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Allan White, with a market cap of $845.4K.
Common questions about Onconetix, Inc.
Onconetix, Inc. is scheduled to report earnings for Q1 2026 on June 11, 2026.
Onconetix, Inc. has approximately 12 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.